HA-TCP (Hydroxyapatite-Tricalcium Phosphate) granules are a biomaterial used in medical and dental applications, particularly in bone grafting procedures. HA-TCP granules are a combination of hydroxyapatite (HA) and tricalcium phosphate (TCP), two calcium-based materials that closely resemble the mineral composition of natural bone. HA-TCP granules are commonly used in orthopedic and dental surgeries, including bone augmentation, sinus lifts, alveolar ridge preservation, and filling bone defects. They serve as a scaffold to support bone regeneration and facilitate the integration of the graft with the surrounding bone tissue.
The global HA-TCP Granules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HA-TCP Granules market research.
Key companies engaged in the HA-TCP Granules industry include CAM Bioceramics, Medicoat, Kyeron, EPRUI, Exabone GmbH, HIMED, TEKNIMED, Maxigen Biotech and NORAKER, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of HA-TCP Granules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole HA-TCP Granules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global HA-TCP Granules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
CAM Bioceramics
Medicoat
Kyeron
EPRUI
Exabone GmbH
HIMED
TEKNIMED
Maxigen Biotech
NORAKER
ChoiceSpine
Biomatlante
Parametrics Medical
Stryker
Advanced Medical Solutions Ltd.
Medtronic
FLUIDINOVA
Segment by Type
200-500µ³¾
500µ³¾-1³¾³¾
1-2mm
Others
Segment by Application
Orthopaedics and Traumatology
Joint revision surgery
Spinal and Neurosurgery
Dental Implantology and Periodontology
Maxillofacial Augmentation and Reconstruction
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The HA-TCP Granules report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Âé¶¹Ô´´ Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Âé¶¹Ô´´ Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global HA-TCP Granules Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 200-500µ³¾
1.2.3 500µ³¾-1³¾³¾
1.2.4 1-2mm
1.2.5 Others
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global HA-TCP Granules Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Orthopaedics and Traumatology
1.3.3 Joint revision surgery
1.3.4 Spinal and Neurosurgery
1.3.5 Dental Implantology and Periodontology
1.3.6 Maxillofacial Augmentation and Reconstruction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HA-TCP Granules Âé¶¹Ô´´ Perspective (2018-2029)
2.2 HA-TCP Granules Growth Trends by Region
2.2.1 Global HA-TCP Granules Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 HA-TCP Granules Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 HA-TCP Granules Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 HA-TCP Granules Âé¶¹Ô´´ Dynamics
2.3.1 HA-TCP Granules Industry Trends
2.3.2 HA-TCP Granules Âé¶¹Ô´´ Drivers
2.3.3 HA-TCP Granules Âé¶¹Ô´´ Challenges
2.3.4 HA-TCP Granules Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top HA-TCP Granules Players by Revenue
3.1.1 Global Top HA-TCP Granules Players by Revenue (2018-2023)
3.1.2 Global HA-TCP Granules Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global HA-TCP Granules Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HA-TCP Granules Revenue
3.4 Global HA-TCP Granules Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global HA-TCP Granules Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HA-TCP Granules Revenue in 2022
3.5 HA-TCP Granules Key Players Head office and Area Served
3.6 Key Players HA-TCP Granules Product Solution and Service
3.7 Date of Enter into HA-TCP Granules Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 HA-TCP Granules Breakdown Data by Type
4.1 Global HA-TCP Granules Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global HA-TCP Granules Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 HA-TCP Granules Breakdown Data by Application
5.1 Global HA-TCP Granules Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global HA-TCP Granules Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America HA-TCP Granules Âé¶¹Ô´´ Size (2018-2029)
6.2 North America HA-TCP Granules Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America HA-TCP Granules Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America HA-TCP Granules Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HA-TCP Granules Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe HA-TCP Granules Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe HA-TCP Granules Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe HA-TCP Granules Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HA-TCP Granules Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific HA-TCP Granules Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific HA-TCP Granules Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific HA-TCP Granules Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HA-TCP Granules Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America HA-TCP Granules Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America HA-TCP Granules Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America HA-TCP Granules Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HA-TCP Granules Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa HA-TCP Granules Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa HA-TCP Granules Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa HA-TCP Granules Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CAM Bioceramics
11.1.1 CAM Bioceramics Company Detail
11.1.2 CAM Bioceramics Business Overview
11.1.3 CAM Bioceramics HA-TCP Granules Introduction
11.1.4 CAM Bioceramics Revenue in HA-TCP Granules Business (2018-2023)
11.1.5 CAM Bioceramics Recent Development
11.2 Medicoat
11.2.1 Medicoat Company Detail
11.2.2 Medicoat Business Overview
11.2.3 Medicoat HA-TCP Granules Introduction
11.2.4 Medicoat Revenue in HA-TCP Granules Business (2018-2023)
11.2.5 Medicoat Recent Development
11.3 Kyeron
11.3.1 Kyeron Company Detail
11.3.2 Kyeron Business Overview
11.3.3 Kyeron HA-TCP Granules Introduction
11.3.4 Kyeron Revenue in HA-TCP Granules Business (2018-2023)
11.3.5 Kyeron Recent Development
11.4 EPRUI
11.4.1 EPRUI Company Detail
11.4.2 EPRUI Business Overview
11.4.3 EPRUI HA-TCP Granules Introduction
11.4.4 EPRUI Revenue in HA-TCP Granules Business (2018-2023)
11.4.5 EPRUI Recent Development
11.5 Exabone GmbH
11.5.1 Exabone GmbH Company Detail
11.5.2 Exabone GmbH Business Overview
11.5.3 Exabone GmbH HA-TCP Granules Introduction
11.5.4 Exabone GmbH Revenue in HA-TCP Granules Business (2018-2023)
11.5.5 Exabone GmbH Recent Development
11.6 HIMED
11.6.1 HIMED Company Detail
11.6.2 HIMED Business Overview
11.6.3 HIMED HA-TCP Granules Introduction
11.6.4 HIMED Revenue in HA-TCP Granules Business (2018-2023)
11.6.5 HIMED Recent Development
11.7 TEKNIMED
11.7.1 TEKNIMED Company Detail
11.7.2 TEKNIMED Business Overview
11.7.3 TEKNIMED HA-TCP Granules Introduction
11.7.4 TEKNIMED Revenue in HA-TCP Granules Business (2018-2023)
11.7.5 TEKNIMED Recent Development
11.8 Maxigen Biotech
11.8.1 Maxigen Biotech Company Detail
11.8.2 Maxigen Biotech Business Overview
11.8.3 Maxigen Biotech HA-TCP Granules Introduction
11.8.4 Maxigen Biotech Revenue in HA-TCP Granules Business (2018-2023)
11.8.5 Maxigen Biotech Recent Development
11.9 NORAKER
11.9.1 NORAKER Company Detail
11.9.2 NORAKER Business Overview
11.9.3 NORAKER HA-TCP Granules Introduction
11.9.4 NORAKER Revenue in HA-TCP Granules Business (2018-2023)
11.9.5 NORAKER Recent Development
11.10 ChoiceSpine
11.10.1 ChoiceSpine Company Detail
11.10.2 ChoiceSpine Business Overview
11.10.3 ChoiceSpine HA-TCP Granules Introduction
11.10.4 ChoiceSpine Revenue in HA-TCP Granules Business (2018-2023)
11.10.5 ChoiceSpine Recent Development
11.11 Biomatlante
11.11.1 Biomatlante Company Detail
11.11.2 Biomatlante Business Overview
11.11.3 Biomatlante HA-TCP Granules Introduction
11.11.4 Biomatlante Revenue in HA-TCP Granules Business (2018-2023)
11.11.5 Biomatlante Recent Development
11.12 Parametrics Medical
11.12.1 Parametrics Medical Company Detail
11.12.2 Parametrics Medical Business Overview
11.12.3 Parametrics Medical HA-TCP Granules Introduction
11.12.4 Parametrics Medical Revenue in HA-TCP Granules Business (2018-2023)
11.12.5 Parametrics Medical Recent Development
11.13 Stryker
11.13.1 Stryker Company Detail
11.13.2 Stryker Business Overview
11.13.3 Stryker HA-TCP Granules Introduction
11.13.4 Stryker Revenue in HA-TCP Granules Business (2018-2023)
11.13.5 Stryker Recent Development
11.14 Advanced Medical Solutions Ltd.
11.14.1 Advanced Medical Solutions Ltd. Company Detail
11.14.2 Advanced Medical Solutions Ltd. Business Overview
11.14.3 Advanced Medical Solutions Ltd. HA-TCP Granules Introduction
11.14.4 Advanced Medical Solutions Ltd. Revenue in HA-TCP Granules Business (2018-2023)
11.14.5 Advanced Medical Solutions Ltd. Recent Development
11.15 Medtronic
11.15.1 Medtronic Company Detail
11.15.2 Medtronic Business Overview
11.15.3 Medtronic HA-TCP Granules Introduction
11.15.4 Medtronic Revenue in HA-TCP Granules Business (2018-2023)
11.15.5 Medtronic Recent Development
11.16 FLUIDINOVA
11.16.1 FLUIDINOVA Company Detail
11.16.2 FLUIDINOVA Business Overview
11.16.3 FLUIDINOVA HA-TCP Granules Introduction
11.16.4 FLUIDINOVA Revenue in HA-TCP Granules Business (2018-2023)
11.16.5 FLUIDINOVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
CAM Bioceramics
Medicoat
Kyeron
EPRUI
Exabone GmbH
HIMED
TEKNIMED
Maxigen Biotech
NORAKER
ChoiceSpine
Biomatlante
Parametrics Medical
Stryker
Advanced Medical Solutions Ltd.
Medtronic
FLUIDINOVA
Ìý
Ìý
*If Applicable.